137 related articles for article (PubMed ID: 23711591)
1. Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze.
Gobira PH; Aguiar DC; Moreira FA
Pharmacol Biochem Behav; 2013 Sep; 110():33-9. PubMed ID: 23711591
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the nitrergic and the endocannabinoid system in rats exposed to the elevated T-maze.
Batista LA; de Araújo Moreira F; Aguiar DC
Acta Neuropsychiatr; 2021 Aug; 33(4):206-210. PubMed ID: 33818338
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB
Batista LA; Moreira FA
Neurosci Lett; 2019 Jun; 703():5-10. PubMed ID: 30858018
[TBL] [Abstract][Full Text] [Related]
4. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
Batista LA; Bastos JR; Moreira FA
J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
[TBL] [Abstract][Full Text] [Related]
5. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
[TBL] [Abstract][Full Text] [Related]
6. Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze.
Sant'Ana AB; Weffort LF; de Oliveira Sergio T; Gomes RC; Frias AT; Matthiesen M; Vilela-Costa HH; Yamashita PS; Vasconcelos AT; de Bortoli V; Del-Ben CM; Zangrossi H
Behav Brain Res; 2016 Dec; 315():115-22. PubMed ID: 27531502
[TBL] [Abstract][Full Text] [Related]
7. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Haller J; Varga B; Ledent C; Freund TF
Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
[TBL] [Abstract][Full Text] [Related]
8. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
Gomes FV; Casarotto PC; Resstel LB; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):434-8. PubMed ID: 21111767
[TBL] [Abstract][Full Text] [Related]
9. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
10. GABA
Frias AT; Fernandes GG; Zangrossi H
Behav Brain Res; 2019 May; 364():99-105. PubMed ID: 30768992
[TBL] [Abstract][Full Text] [Related]
11. Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack.
Batista LA; Haibara AS; Schenberg LC; Moreira FA
Behav Brain Res; 2017 Jan; 317():508-514. PubMed ID: 27737792
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
Roncon CM; Biesdorf de Almeida C; Klein T; de Mello JC; Audi EA
Planta Med; 2011 Feb; 77(3):236-41. PubMed ID: 20845263
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
[TBL] [Abstract][Full Text] [Related]
14. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
16. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
[TBL] [Abstract][Full Text] [Related]
17. Effects of cannabinoids on the anxiety-like response in mice.
Rutkowska M; Jamontt J; Gliniak H
Pharmacol Rep; 2006; 58(2):200-6. PubMed ID: 16702621
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze.
Pinheiro SN; Del-Ben CM; Zangrossi H; Graeff FG
J Psychopharmacol; 2008 Mar; 22(2):132-7. PubMed ID: 18208911
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Cagni P; Barros M
Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
